arbitration or other action which has been resolved without the payment of any fine or penalty on the part of the Company or its subsidiaries nor, to the knowledge of the Company, is any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened. Except as would not, individually or in the aggregate, have a Material Adverse Effect: the Company and its subsidiaries have filed, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any applicable Health Care Laws and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and accurate on the date filed (or were corrected or supplemented by a subsequent submission). The Company or its subsidiaries is not a party to any material corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders or similar agreements with or imposed by any governmental or regulatory authority, or has any reporting obligations, plan of correction or other remedial measures entered into pursuant to any such agreement entered into with, or such decree or order issued by, any such governmental or regulatory authority with respect to any Health Care Law. Additionally, none of the Company, any of its subsidiaries nor any of its or their respective employees, officers or directors, or, to the knowledge of the Company, agents, is listed as disqualified, excluded, suspended or debarred by any governmental or regulatory authority or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, inquiry, proceeding, or other similar action that could reasonably be expected to result in disqualification, debarment, suspension, or exclusion;
(mm) Except as would not, individually or in the aggregate, have a Material Adverse Effect: the Company and its subsidiaries have submitted and possess, or qualify for applicable exemptions to, such valid and current Permits issued or required by the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct their businesses as currently conducted as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus (collectively, the Authorizations), including, without limitation, all such Authorizations required by the HHS, FDA or any other state, federal or foreign agencies or bodies that regulate, oversee, or are engaged in research, nonclinical studies, preclinical studies, clinical trials, tests or studies (including human subjects research), or the products that are the subject of such studies, and the Company or its subsidiaries has not received any written notice of proceedings relating to the revocation, termination, limitation, suspension or material adverse modification of, or material non-compliance with, any such Authorization;
(nn) Since January 1, 2016, the services, products, operations, and activities of the Company that are described in the Registration Statement, Pricing Sale Prospectus, and the Prospectus (collectively, Services) were and, if still pending, are being conducted in all material respects in accordance with all applicable Health Care Laws; and none of the Company or its subsidiaries has received any written notice of, or written correspondence from, any governmental or regulatory authority alleging or asserting material noncompliance of such Services with applicable Health Care Laws. To the knowledge of the Company, no governmental or regulatory authority is considering such action.
(oo) Except (i) as described in the Registration Statement, the Pricing Sale Prospectus and the Prospectus or (ii) as would not reasonably be expected to have a Material Adverse Effect, with respect to each Government Contract (as defined below): (A) during the five years prior to the date hereof, (1) the Company and each of its subsidiaries has complied with all laws, regulations and requirements applicable to Government Contracts or Government Proposals (as defined below) and the terms and conditions of (including all representations and certifications relating to) each Government Contract and Government Proposal, including compliance with accounting requirements; (2) neither the Company nor any of its subsidiaries nor any of their